INVO BioScience(INVO) - 2019 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Nevada 20-4036208 (I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation or organization) 407 Rear Mystic Avenue, Suite 34C, Medford, MA 02155 (Address of principal executive offices, including zip code) For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...